Market Currents
Neoprobe (NEOP +4.8%) shares are higher today after submitting a new drug application to the FDA...
-
Thursday, August 11, 2011, 12:48 PM ETNeoprobe (NEOP +4.8%) shares are higher today after submitting a new drug application to the FDA for its cancer detection platform Lymphoseek. The company seeks clearance to market it for use in surgical oncology procedures.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
